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Abstract 
Objective: Rapid-Eye-Movement (REM) sleep behaviour disorder (RBD) is an early predictor of 
Parkinson’s disease, dementia with Lewy bodies, and multiple system atrophy. This study investigates 
a minimal set of sensors to achieve effective screening for RBD in the population, integrating 
automated sleep staging (three state) followed by RBD detection without the need for cumbersome 
electroencephalogram (EEG) sensors.  
Methods: Polysomnography signals from 50 participants with RBD and 50 age-matched healthy 
controls were used to evaluate this study. Three stage sleep classification was achieved using a 
Random Forest (RF) classifier and features derived from a combination of cost-effective and easy to 
use sensors, namely electrocardiogram (ECG), electrooculogram (EOG), and electromyogram (EMG) 
channels. Subsequently, RBD detection was achieved using established and new metrics derived from 
ECG and EMG metrics.  
Results: The EOG and EMG combination provided the best minimalist fully automated performance, 
achieving 0.57±0.19 kappa (3 stage) for sleep staging and an RBD detection accuracy of 0.90±0.11, 
(sensitivity, and specificity 0.88±0.13, and 0.92±0.098). A single ECG sensor allowed three state sleep 
staging with 0.28±0.06 kappa and RBD detection accuracy of 0.62±0.10.  
Conclusions: This study demonstrated the feasibility of using signals from a single EOG and EMG sensor 
to detect RBD using fully-automated techniques.  
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Significance: This study proposes a cost-effective, practical, and simple RBD identification support tool 
using only two sensors (EMG and EOG), ideal for screening purposes.   
Keywords 
Automated sleep staging; electrocardiogram; electrooculogram; electromyography; Parkinson’s 
disease; polysomnography; REM sleep behaviour disorder; RBD; sleep diagnostic tool. 
Highlights  
 This study proves the feasibility of an effective screening tool that simply uses an EMG, EOG 
or ECG sensors for fully automated RBD detection.  
 The REM sleep stage was accurate and detected reliably in individuals with RBD without the 
use of EEG.  
 Automated sleep staging achieved high positive predictive value of REM sleep stage and 
ensured RBD detection performance was also high. 
This research was supported by the Research Council UK (RCUK) Digital Economy Programme (Oxford 
Centre for Doctoral Training in Healthcare Innovation -- grant EP/G036861/1), Sleep, Circadian 
Rhythms & Neuroscience Institute (SCNi -- 098461/Z/12/Z), Rotary Foundation, National Institute for 
Health Research (NIHR) Oxford Biomedical Research Centre (BRC), Engineering and Physical Sciences 
Research Council (EPSRC -- grant EP/N024966/1), and Parkinson’s UK: Targeting the pathological 
pathways to Parkinson’s (grant J-1403). The content of this article is solely the responsibility of the 
authors and does not necessarily represent the official views of the RCUK, SCNi, NIHR, BRC or the 
Rotary Foundation. 
Conflict of interest 
None of the authors have potential conflicts of interest to be disclosed.  
1. Introduction 
In the search for an early predictor for the onset of Parkinson’s disease, few are as promising as Rapid-
Eye-Movement (REM) Sleep behaviour disorder (RBD). Recent literature estimates 73.5% conversion 
of RBD to an overt neurodegenerative syndrome after a 12-year follow-up with a 6% risk of conversion 
per year (Postuma et al. 2019). To further explore the mechanisms behind these conversions and to 
develop neuroprotective therapies, larger cohorts of individuals with RBD must be identified. The 
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greatest hurdle to designing such studies is the slow and arduous RBD diagnostic process involving 
polysomnography (PSG) recordings within sleep clinics, which are often under-staffed and 
oversubscribed (severely limiting availability). PSG recordings are expensive, time consuming to setup, 
can be uncomfortable and rely on labour intensive visual inspection of PSG data. Previous studies have 
demonstrated that automated sleep staging and RBD detection was possible from a limited PSG 
consisting of a electroencephalogram (EEG), electrooculogram (EOG), and electromyogram (EMG) 
sensor (Cooray et al. 2018, 2019). This limited framework validates the possibility of a practical and 
comfortable take-home device for sleep evaluation, of which only a limited number of clinical grade 
devices supported by literature exist (Mikkelsen et al. 2017; Sterr et al. 2018).  
Recent sleep research is uncovering an interplay between the central nervous system (CNS) and the 
autonomic nervous system (ANS) that is regulated throughout sleep and its various stages (de 
Zambotti et al. 2018). The ANS is responsible for regulating the majority of the body’s internal systems, 
such as blood pressure, breathing, body temperature, digestion, urine, and myocardial function. Of 
particular interest is the change in heart rate variability (HRV) during sleep and how it might be 
interpreted for automated three state sleep staging (Redmond and Mcnicholas 2007; Mendez et al. 
2010; Xiao et al. 2013; Ebrahimi et al. 2015; Fonseca et al. 2015; Malik et al. 2018; Yücelbaş et al. 
2018). For these studies automated sleep staging from ECG based features were achieved for three 
sleep states, wake (W), REM and non-REM (REM). Additionally, recent literature indicated cardiac 
autonomic dysfunction as a characteristic of RBD (Postuma et al. 2010; Sorensen et al. 2013; Bugalho 
et al. 2018). Postuma et al. (2010) demonstrated through RR standard deviation and low frequency 
components that there is a clear autonomic dysfunction in RBD participants compared to healthy 
controls. Similarly, Sorenson et al. (2013) illustrated attenuated sympathetic activity in heart rate 
variability in participants with PD and/or RBD compared to healthy controls. Bugalho et al. (2018) 
attributed to RBD participants a reduction in parasympathetic modulation of heart rate variability in 
relation to sleep stage transitions. Heart rate and heart rate variability (HRV) are commonly used to 
evaluate components of ANS functionality (Andreotti et al. 2018), conventionally measured by 
electrocardiogram (ECG) sensors. ECG sensors are ubiquitous and user-friendly and therefore provide 
an opportunity to further economise sleep staging and RBD detection by excluding the need for 
cumbersome and expensive EEG sensors.  
Furthermore, single sensor studies in sleep staging have been proposed for EOG and EMG sensors, 
which aim to be more economical whilst producing similar performances to EEG electrodes (Virkkala 
et al. 2007, 2008; Yetton et al. 2016). With respect to RBD detection, our previous work utilised 
established objective techniques to evaluate REM sleep without atonia (RWSA) and demonstrated 
how they could be improved using a combination of EMG metrics that incorporate sleep architecture 
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(Cooray et al. 2018, 2019). We will investigate the inclusion of ECG based metrics that exploit changes 
in ANS, as a substitute or enhancement for RBD detection. Consequently, using a simplified 
combination of ECG, EOG and EMG sensors, this study explored the feasibility of simpler RBD 
screening, being minimalistic while proving as effective at identifying RBD compared to conventional 
full PSG techniques.  
2. Data 
PSG recordings used in this study were collected from several sources and included participants 
diagnosed with RBD and age-matched healthy controls (HCs), detailed in Table 1. The Montreal 
Archive of Sleep Studies (MASS) cohort one (O’Reilly et al. 2014) provided 53 HC individuals, where 
three were excluded due to their poor ECG signal fidelity (specifically, participants labelled SS01, SS10, 
and SS18). Clinically diagnosed participants with idiopathic RBD were collated from the Physionet 
Cyclic Alternating Pattern (CAP) sleep database (22 RBD participants) (Goldberger et al. 2000; Terzano 
et al. 2001) and a private database of RBD participants from the John Radcliffe (JR) hospital (35 
participants), Nuffield Department of Clinical Neurosciences at the University of Oxford. While the JR 
dataset included two nights of full PSG recordings for each participant, this study simply used the 
second night, where available (only two participants had a single night recording). Eight participants 
from the CAP database were excluded because one was a duplicate recording (RBD11) and seven had 
secondary RBD, including five diagnosed with PD (RBD1, RBD2, RBD3, RBD7, and RBD9), one with 
multiple systems atrophy (RBD13), and one with Lewy body disease (RBD5). Consequently, this 
combined RBD cohort provided a total of 50 RBD participants, of which two were taking Clonazepam 
to treat their condition, while ten participants were taking anti-depressants (Citalopram, Venlafaxine, 
Sertraline, Duloxetine, and Lorazepam) to treat REM sleep without atonia (RSWA). All RBD participants 
had an apnoea-hypopnea index (AHI) of less than 7.1 and were evaluated as being mild and 
unremarkable, except for one participant (RBD1) from the CAP sleep database with a severe index of 
30/h (previously excluded for secondary RBD). Five RBD participants with concurrent RBD and 
obstructive sleep apnoea (OSA) wore a continuous positive airway pressure ventilator at the time of 
their PSG recordings, which would benefit their AHI score. This study complied with the requirements 
of the Department of Health Research Governance Framework for Health and Social Care 2005 and 
was approved by the Oxford University hospitals NHS Trust (HH/RA/PID 11957). These two RBD 
datasets were combined to balance the HC recordings provided by the MASS database. Furthermore, 
this combination provides an opportunity to evaluate how generalizable this study is over differing 
datasets annotated at different institutions. Once more by using openly available datasets (MASS and 
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CAP), this study can be reproduced in combination with the toolbox provided at 
https://github.com/navsnav/Minimal-RBD-Sleep-Detection. 
Annotations of the PSG recordings were completed by experts using either the Rechtschaffen and 
Kales (R&K) (Rechtschaffen and Kales 1968) or AASM guidelines (Iber et al. 2007). For the purposes of 
this study, these set of rules are easily converted to three stages (REM, NREM, and W), where NREM 
is defined by S1, S2, S3, S4, N1, N2 or N3. To explore the most economical combination of sensors, the 
following signals were analysed: 
● 1 ECG (2 electrodes - Einthoven derivation) 
● 1 EOG (2 electrodes – bipolar signal) 
● 1 EMG (2 electrodes – submentalis) 
Numerous studies have used limited sensors to assess automated sleep staging, but for this study we 
applied automated sleep staging on healthy and RBD participants followed by automated RBD 
identification.  
3. Method 
3.1 Pre-processing 
To reduce the impact of noise and artefacts, PSG signals were pre-processed. Firstly, all ECG, EOG and 
EMG signals were resampled at 200Hz. The EOG signal was pre-processed with a 500th order band pass 
finite impulse response (FIR) filter with a cut-off frequency of 0.3Hz and 40Hz. The EMG signal was 
filtered with a 500th order notch filter at 50Hz and 60Hz (because the recordings were sourced from 
either Europe or Canada), in addition to a 500th order band pass FIR filter between 10Hz and 100Hz. 
The ECG signal was filtered by a 10th order Butterworth band pass filter between 5Hz and 45Hz.  
3.2 Feature Extraction 
Feature extraction for EOG and EMG signals were as described in our previous study (Cooray et al. 
2019), based on established literature in automated sleep staging (Güneş et al. 2010; Koley and Dey 
2012; Liang et al. 2012; Lajnef et al. 2015; Yetton et al. 2016). Literature that described ECG features 
for automated sleep staging provided motivation for this study (Redmond and Mcnicholas 2007; 
Mendez et al. 2010; Xiao et al. 2013; Ebrahimi et al. 2015; Fonseca et al. 2015; Yoon et al. 2017; Malik 
et al. 2018; Yücelbaş et al. 2018) and are summarised in Table 2. For this study the pre-processed ECG 
signal was segmented into five-minute epochs, often used for HRV analysis (Ebrahimi et al. 2015). 
Features were then derived after Pan-Tompkins QRS detection (Pan and Tompkins 1985) from each 
30-second segment. These features were then averaged across a moving 150-second sliding window, 
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demonstrated in other similar studies (Redmond and Mcnicholas 2007; Xiao et al. 2013; Fonseca et al. 
2015).  
3.3 Automated Sleep Stage Classification 
The Random Forest (RF) algorithm (Breiman 2001) has proven effective for automated sleep staging 
and was used for this study. The classifier was trained to classify 30-second epochs into one of three 
sleep stages (REM, NREM and W) using a combination of 25 EOG features, 17 EMG features and 75 
ECG features, as described in Table 2 (the number of trees was set to 500, 𝑚𝑡𝑟𝑦 = √𝑀 (rounded down) 
randomly selected features, where 𝑀 is the total number of features (detailed in Table 4)). For each 
of the three sleep stages the classifiers were evaluated using macro-averaged sleep stage accuracy, 
sensitivity, specificity, and Cohen-Kappa score (three stage) by using 10-subject-fold cross-validation 
with an even split between healthy and RBD participants. Additionally, multi-stage classification was 
assessed by Cohen’s Kappa (Cohen 1960), a metric often used in sleep staging to evaluate the 
agreement between manual and automated annotations. These performances were compared to 
results obtained using EEG, EOG and EMG features described in Cooray et al (2019). Our previous work 
demonstrated that accurate automated sleep staging (especially REM detection) yielded a high 
performance in RBD detection. 
3.4 RBD Detection 
In RBD diagnosis, literature stipulates that after the identification of REM sleep, RSWA must be 
confirmed visually (Sateia 2014). In our previous work we demonstrated that established features, 
which quantify RSWA in combination with sleep architecture, provided RBD detection performances 
approaching that of the gold standard (manual clinical diagnosis) by using RF classifiers (Cooray et al. 
2018, 2019). This study emulated previous results and compared them to RBD detection using 
additional ECG based metrics in isolation and combination with EMG based metrics through RF 
classification.  
RF classifiers were used to achieve RBD detection, as per the combinations detailed in Table 5. 
Classifiers were trained using 500 trees; 𝑚𝑡𝑟𝑦 = √𝑀 (where M is the number of features detailed in 
Table 5), and evaluated using a 10-subject-fold cross-validation scheme. In addition to the features 
detailed in our previous study, we proposed new ECG features that capture changes in heart rate 
variability between sleep stages (see Table 3Error! Reference source not found.).  
A summary of all ECG based metrics that incorporate sleep architecture and HRV in order to identify 
RBD are detailed in Table 3. Specifically, to quantify the variability, the mean sample entropy for each 
REM epoch was calculated for every participant. Similarly the standard deviation of the RR intervals 
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for every REM epoch was averaged for all participants. Often low frequency and high frequency 
components of RR intervals are used to describe sympathetic and parasympathetic activity in the 
autonomic nervous system, and as a result the mean peak low frequency and high frequency was 
calculated for all participants. To capture the changes in heart rate variation between sleep stages, 
the ratio between REM and NREM values was calculated for the mean RR interval. The low frequency 
and high frequency ratio is a popular feature used in heart rate variability, and the ratio between 
NREM and REM epochs was calculated for each participant as an RBD metric. Literature has also 
suggested that PD is significantly comorbid with atrial fibrillation (AF) (Hong et al. 2019), consequently 
the metrics termed irregular index and origin count (Sarkar et al. 2008; Oster and Clifford 2015) were 
used to quantify irregularly irregular heartbeats during NREM and REM sleep. These ECG based 
metrics were used to automatically identify RBD participants and were compared to metrics from our 
previous studies (Cooray et al. 2018, 2019).  
Furthermore the RBD detection performance for these metrics were evaluated using manually and 
automatically annotated sleep staging using the best combination of minimal sensors (see Table 4), in 
order to validate their use in an end-to-end RBD screening support tool. The impact of automated 
sleep staging on the calculation of these metrics was also carefully analysed.   
The fidelity and consistency of these ECG based metrics derived though manually and automatically 
annotated sleep staging were evaluated by Bland and Altman (B&A) plots (Bland and Altman 1986, 
1995, 1999). B&A plots were introduced to describe the agreement between two quantitative 
measures as an improvement to simple correlation factors. While correlation factors provide the 
strength of a linear relationship, they do not imply a good agreement between two methods. The B&A 
plot measures agreement by plotting the mean against the difference of both quantitative methods 
(Bland and Altman 1986), while constructing the limits of agreement (where Bland and Altman et al. 
recommend that 95% of all data points fall within two standard deviations of the mean difference). 
Furthermore, B&A plots detail the bias between the mean differences of both quantitative methods 
and their significance. For this study B&A plots were used to establish a level of agreement between 
RBD metrics, derived using manually and automatically annotated sleep stages within a certain 
agreement interval. The decision on whether these intervals are acceptable must be decided by 
clinical evaluation and in our case through the performance of automated RBD detection with metrics 
derived from automated sleep staging.    
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4. Results 
The following results are presented in three sections, detailing 1) automated sleep stage classification, 
2) RBD detection using automatically annotated sleep stages, and 3) Bland and Altman plots for RBD 
metrics using automatically/manually annotated sleep stages.   
4.1 Automated Sleep Stage Classification 
The best performance of automated sleep staging was provided by all three signals (EOG, ECG, and 
EMG) attaining an agreement score of 0.58 (0.70 and 0.48 for the individual HC and RBD cohort, 
respectively). These results are also comparable to our previous study that included EEG features 
(Cooray et al. 2019), shown in Figure 1 as combination Z3 (EEG, EOG, and EMG). Once again it is clear 
that the automated sleep staging performs considerably better on HC participants than RBD 
participants, echoing the results from our previous study (Cooray et al. 2019). The best performing 
combination of two sensors proved to be the EOG and EMG sensors (C2), followed by the EOG and 
ECG combination (A2) achieving a 0.57 and 0.51 agreement score, respectively. While combining ECG 
and EMG features attained an agreement score of 0.41. The best single sensor performance was given 
by EOG features (see Figure 1 B1), achieving a three-stage score of 0.50, considered moderate 
agreement (Landis and Koch 1977). The single ECG and EMG sensor (A1 and C1, respectively) had 
limited success, never exceeding fair agreement (0.30 and 0.28, respectively).   
The ranked feature importance in REM detection are detailed in Figure 2, for (a) ECG features and for 
(b) combined EOG, ECG and EMG features. From Figure 2 (a) it appears elapsed time is the most 
important, followed by zero crossing interval (ZCI) and RR interval based features. In Figure 2 (b) EOG 
features dominate the list of important features, while EMG and ECG features make an appearance in 
the top 30.  
4.2 RBD Detection with ECG Metrics 
The performances of RBD detection by ECG and EMG metrics are depicted in Figure 3. ECG metrics 
proved they are able to distinguish RBD participants with an accuracy, sensitivity, and specificity of 
0.62±0.20, 0.56±0.23, and 0.68±0.24, respectively. The combination of EMG metrics and sleep 
architecture (detailed in our previous study) achieved an accuracy, sensitivity and specificity of 
0.93±0.09, 0.92±0.13, and 0.94±0.092, respectively. Combining EMG and ECG metrics for RBD 
detection provided a similar accuracy, sensitivity, and specificity of 0.93±0.10, 0.94±0.092, and 
0.92±0.13, respectively. 
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The ranking of ECG and/or EMG metrics for RBD detection are depicted in Figure 4.  Simply using ECG 
metrics (Figure 4 (a)) indicated that NREM origin count (a measure or regular heart beats) and NREM 
irregular index (IrrIndex, a measure of irregularly irregular heartbeats) and the ratio or NREM sleep 
were the most valuable. Figure 4 (b) ranks EMG metrics, where the atonia index ratio (between NREM 
and REM), atonia index (REM) and the fractal exponent ratio (between NREM and REM) proved to be 
the most important. ECG and EMG metrics used in combination (Figure 4 (c)), demonstrated that EMG 
metrics remain the best identifiers in a similar order to Figure 4 (b).  
Figure 5 details the best RBD detection performance from automated sleep staging classifiers using a 
combination of EOG, ECG and EMG features. The best performance (F1 score) was given by C2D2 
(three sensors - EOG and EMG for sleep staging followed by EMG and ECG for RBD detection), followed 
by C2E1 combination (two sensors - EOG and EMG for sleep staging followed by EMG for RBD 
detection) with an accuracy, sensitivity, specificity and F1 score of 0.90±0.11, 0.88±0.13, 0.92±0.098, 
and 0.90±0.12. These results are similar and only marginally less than when using a cumbersome EEG 
combination (Cooray et al. 2019), depicted by Z3 (Figure 5). 
4.3 RBD Metrics from Automated and Annotated Sleep Staging (Bland-Altman) 
The impact of RBD metrics calculated from automated sleep staging from a single EOG and EMG is 
evaluated by the Bland-Altman plots given in Figure 6. A selection of important RBD metrics (provided 
by Figure 4) appear to provide agreeable results where the limits of agreement are represented by 
horizontal dotted lines. The mean difference bias is defined by the solid black line in Figure 6, where 
of the top three EMG and ECG based metrics all appear to have a slight bias when using automated 
sleep staging (shaded area around mean difference includes zero).  
5. Discussion 
The aim of this study was to investigate a minimalistic approach for identifying RBD through a fully 
automated pipeline. This study excluded the use of cumbersome-to-apply EEG sensors and instead 
focused on a combination of ECG, EOG and EMG sensors to achieve automated three-stage sleep 
classification and RBD identification. The use of EOG and EMG sensors for automated sleep staging 
proved the most effective, achieving REM detection that was comparable with the literature and near 
human expert annotation (Figure 1). Not surprising given visual staging (especially REM) relies heavily 
on EOG and EMG signals. Furthermore this study validated the use of ECG based RBD metrics to 
identify RBD using an RF classifier (Figure 3). Once more the performance of RBD detection remained 
high when using automated sleep staging from EOG and EMG features (Figure 5 and Table 7). This can 
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be attributed to the high positive prediction value and specificity provided by the automated sleep 
staging that facilitated congruent RBD metrics (Figure 6).  
As has been established in literature, the inter-rater variability of manual sleep staging is high and is 
exacerbated further by sleep disorders that provide additional variation in sleep characteristics 
(Danker-Hopfe et al. 2004, 2009). This was also demonstrated in our previous study, where automated 
sleep staging performed better on HCs than RBD participants (Cooray et al. 2019) and was again 
observed in this study (for all combination of sensors). For a single ECG sensor, sleep staging was 
particularly difficult for RBD participants. 
The automated three-stage classification performance of ECG features (Table 6) on a combined 
dataset (kappa of 0.30), reflected the lower range of results achieved by similar studies (kappa 
between 0.35 and 0.73) (Redmond and Mcnicholas 2007; Xiao et al. 2013; Fonseca et al. 2015; 
Yücelbaş et al. 2018). However these studies benefit from smaller datasets focusing on relatively 
younger HCs (participants of 28 to 48 people with a mean age that varies from 41 to 43).  Yücelbas et 
al. (2018) achieved the highest score of 0.74, but even this technique applied to another dataset 
achieved a kappa of 0.43 and for participants with OSA scored between 0.52 and 0.57, indicating a 
high degree of variability (Yücelbaş et al. 2018). Xiao et al. (2013) had the added benefit of using 
manually annoated ECG segments, termed “stationary”, achieving a score of 0.47 (Xiao et al. 2013).  
Interestingly, while this study acheives a kappa score of 0.30 (ECG features) on a mixed cohort of 100 
participants, the RBD cohort severely underperforms with respect to REM detection. This was due to 
a misclassification of REM states for NREM and wake, potentially caused by changes to HRV regulation 
and from movement artefacts, which might be attributed to symptoms of RBD. The feature 
importance for REM detection, detailed in Figure 2 (a), ranks elapsed-time as more indicative than 
ECG features. Elapsed time is the progression of time since the beginnng of the first annoated epoch 
from the PSG recording. This feature might benefit from the sleep technician that arbritarily starts 
annotating sleep stages from a point they deem appropriate or around the time of lights off. While 
this attribute might not be directly applicable to a fully automated take-home screening device, there 
is the near equivalent arbitrary starting point determined by the sleep participant at around the time 
of lights off. Participants often provide a signature to ensure synchronisation between recording 
devices or simply to indicate lights off. The highest ranked ECG features included RR intervals and ZCI, 
which are illustrative of HRV but ultimately these features do not contribute towards high REM 
detection sensitivity.  
Alternatively, EOG features provided a boost to automated sleep staging performance (kappa score 
of 0.50 and mean REM F1 score of 0.52), as shown in Figure 1. These results are comparable to EOG 
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sleep staging literature that achieved four-state kappa scores of 0.59 (Virkkala et al. 2008) and REM 
F1 scores of 0.64-0.80 (Agarwal et al. 2005; Virkkala et al. 2008; Yetton et al. 2016). It is clearly evident 
that for automated sleep staging, the ability of ECG features is superceded by EOG features. 
Combining EMG and EOG features, further improved automated sleep staging with a kappa of 0.57 
and mean REM F1 score of 0.62. Using all three sensors (EOG, EMG, and ECG) provided an almost 
negligible improvement (kappa score of 0.58 and mean REM F1 score of 0.60). Essentially providing 
no additional merit for an additional ECG sensor, which would only add cost and hassel to a potential 
screening support tool. The inclusion of EEG features (Z3 combination, see Figure 1), as per our 
previous study (Cooray et al. 2019), provided only a marginal improvement to REM detection, but 
markedly improved three-stage kappa, due to improved NREM and wake classification (kappa score 
of 0.72 and mean REM F1 score of 0.62).  
The feature ranking for REM detection, when using all signals, are detailed in Figure 2 (b). The 
prevalance of EOG features only confirms their correlation with REM sleep and specifically detecting 
rapid eye movement through permutation entropy, max peak amplitude, and coastline features. In 
the ranking order, these features are closely followed by elapsed time and EMG features that measure 
muscle atonia (amplitude percentile, entropy, and relative power). The addition of ECG features did 
not improve EOG, EMG or EOG and EMG combinations, indicating that these features are often 
redundant and perhaps only help to reduce variation (see Figure 1). While ECG features did not appear 
fruitful in automated sleep staging, they had some success in RBD detection. 
RBD classification through ECG metrics proved effective but ultimately did not outperform EMG 
metrics (see Figure 3). The ECG metric ranking for RBD detection ((a)) indicates that NREM origin count 
and NREM irregular index as the most informative. Literature describes a loss in HRV regulation during 
REM (Postuma et al. 2010; Sorensen et al. 2013; Bugalho et al. 2018) and differences in atrial 
fibrillation (Hong et al. 2019) in individuals diagnosed with RBD. Combining EMG and ECG metics 
provided a marginal improvement to RBD detection, with regards to the F1 score (Figure 3). This 
suggests that ECG and EMG metrics are correlated, in that a reduction of HRV regulation during REM 
is synonymous with a loss of muscle atonia. The impact of automated sleep staging on RBD detection 
was also evaluated using the most successful combinations of sensors (detailed in Figure 1).  
The performance of RBD detection using the best sensor combinations for both automated sleep 
staging and RBD classification are detailed in Figure 5. The boost in performance from using more than 
one sensor for sleep staging can be observed in C2E1, C2D2, and A3D2 (multiple sensors) compared 
to B1D1, B1E1, and B1D2 (single EOG sensor). Previously our results confirmed that C2 and A3 provide 
better REM detection sensitivity compared to B1 (Figure 1), thereby enabling better RBD detection 
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through better REM classification. Interestingly, when using automated sleep staging (C2 – EOG and 
EMG), RBD detection using ECG metrics (C2E1) are equivalent to EMG metrics (C2D2), see Figure 5. 
Once again proving that there is considerable overlap in the discriminating abilities of both these 
metrics, where performance can be differentiated with better REM detection. In terms of achieving 
economy and efficiency, C2E1 used two sensors (EOG and EMG) compared to three for C2D2 and A3D2 
(EOG, EMG and ECG), a potential advantage for a simple and cost-effective screening tool. 
Furthermore these results are comparable to results derived using EEG features illustrated by the Z3E1 
combination, thereby bypassing the complications of applying EEG electrodes.  
From Table 7 we can observe the RBD detection results using manually and automatically annotated 
sleep staging (using the minimalistic combination of a EMG and EOG sensor). While RBD detection 
performance dropped slightly when using automated sleep staging, it still remained high (mean 
accuracy, sensitivity and specificity of 0.90, 0.88, and 0.92, respectively).   
Bland-Altman analysis was used to evaluate the agreement between metric quantification using 
manually and automatically annotated sleep staging from the C2 combination (EOG and EMG). Figure 
6 (a)-(e) provides the Bland-Altman plots for the best metrics for RBD detection using the EMG sensor 
(atonia index, fractal exponent, and atonia index ratio) and the ECG sensor (irregular index, RR interval 
index ratio, and NREM origin count) as detailed in Figure 6. From these plots it is clear that automated 
sleep staging (derived from EOG and EMG features) sufficiently produced RBD metrics that were 
correlated to metrics derived from manually annotated sleep staging. However we can observe a bias 
introduced to RBD metrics derived from automatically annotated sleep staging, where the mean 
difference (solid black line in Figure 6) and its’ confidence interval (grey shadded area) does not include 
the line of equality (zero axis, dotted line through the origin). This is the direct result from automated 
sleep stage misclassification. When REM is misclassifed for NREM and wake, the impact on the 
calculation of RBD metrics provides a bias towards values ascociated with NREM and wake sleep. 
Because automated sleep staging was poorest on RBD participants (red circles), we observed a greater 
variation in the y-axis (difference), especially as the x-axis values (mean value) moved towards values 
ascociated with RBD (red circles). Note that the limits of agreement are calculated by assuming that 
the difference between the metrics calculated from manually and automatically annotated sleep 
stages are normally distributed, however this isn’t strictly necessary (Bland and Altman 1999). From 
these plots we can observe the resilience and fidelity of these metrics using automated sleep staging 
from the most successful combination of minimal PSG sensors (EOG and EMG).  
These results validate a cost-effective and readily accessible take-home sleep device for RBD screening 
purposes using only an EOG and EMG sensor. However, often epidemiological studies incur much 
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greater costs for logistical reasons and include additional sensors to optimise their collection of data 
and therefore include ECG and EEG sensors. Often wearable devices and general sleep recordings are 
plagued with inconsistent and intermittent signals, given the unpredictability and difficulty of self-
administered devices outside of a clinical setting. This study overcomes these issues and further 
supports retrospective and prospective studies by demonstrating the redundancy and ability of these 
sensors to function interchangeably for both automated sleep staging and RBD detection. 
6. Limitations & Future Direction 
While this study included a high number of participants, its application in a clinical setting are limited 
because it simply focused on HC and RBD cohorts. A clinical application would demand greater 
resilience to a myriad of sleeping disorders and other population variations that could easily share 
confounding RBD attributes. These include periodic limb movement of sleep, OSA, parasomnias, and 
severe insomnia (very fragmented sleep), which should also be included and evaluated. While ECG 
metrics did not prove as effective in RBD detection as EMG metrics, there is still no clear indication of 
which characteristic manifests earlier in RBD participants, loss of REM atonia or loss of HRV regulation 
during sleep. The loss of HRV regulation might even provide an early bio-marker for RBD, and could 
potentially offer insight into the PD conversion of RBD participants, although literature exists that 
suggests there is currently no correlation for the latter (Postuma et al. 2010). This study also confirmed 
that successful REM detection is paramount to effective RBD detection and future work to improve 
automated REM detection would only prove beneficial. Advances in deep learning techniques are 
achieving promising results and may prove useful in this context (Supratak et al. 2017; Phan et al. 
2019). Furthermore applying these tools on wearable data would be the next logical step forward 
towards validating a fully automated RBD detection pipeline.  
7. Conclusion 
This study proved the feasibility of a fully automated pipeline for RBD detection using an EOG and 
EMG sensor. This study achieved automated sleep staging comparable to manual annotation, which 
translated to a high performance in RBD detection. Once more this study verified RBD detection 
through ECG based metrics (NREM irregular index, RR interval index ratio and REM RR interval 
standard deviation) were effective but did not out-perform EMG based metrics. Furthermore their use 
in automated sleep staging provided very little benefit and may not be worth the additional sensor for 
a minimalistic and economical RBD screening tool.  
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Table & Figures 
Database Cohort Age #Subjects #Female #Male 
CAP RBD 70.2±5.3 14 2 12 
JR RBD 64.3±8.0 36 2 34 
Combined (CAP/JR) RBD 68.0±7.8 50 4 46 
MASS  Elderly-HC 63.7±5.2 50 17 33 
Table 1: Datasets used in the study. Recordings from individuals with RBD are collected from the JR and CAP datasets and 
have been combined (CAP/JR). Note the male predominance within the RBD dataset. These datasets are analysed separately 
for sleep stage classification and combined for abnormal EMG calculation and RBD detection.   
Channel Category Name Description Reference 
ECG Non-linear IrrIndex  Irregular Index, a feature derived from Lorenz plots from RR 
intervals. Originally termed atrial fibrillation evidence. 
(Sarkar et al. 2008) 
ECG  Time RR Interval The mean and median RR interval. Calculated also for 
normalised RR intervals 
(Andreotti et al. 2018) 
ECG Time SDNN The standard deviation of the standard deviation of the NN 
interval. Also a normalised value is calculated. 
(Andreotti et al. 2018) 
ECG Time RMSSD Square root of mean of squares of difference between adjacent 
NN interval 
(Andreotti et al. 2018) 
ECG Time SDSD Standard deviation of differences between adjacent NN 
intervals 
(Andreotti et al. 2018) 
ECG Time NN50 Number of pairs of adjacent NN intervals differing by more 
than 50ms 
(Andreotti et al. 2018) 
ECG Time pNN50 Percentage NN50 (NN50/total number of NN intervals) (Andreotti et al. 2018) 
ECG Frequency LFpeak Frequency of maximum peak in low frequency range. Also 
calculated with normalised value. 
(Andreotti et al. 2018) 
ECG Frequency HFpeak Frequency of maximum peak in high frequency range. Also 
calculated with normalised value. 
(Andreotti et al. 2018) 
ECG Frequency Totalpower Also calculated with normalised value. (Andreotti et al. 2018) 
ECG Frequency LFpower Also calculated with normalised value. (Andreotti et al. 2018) 
ECG Frequency HFpower Also calculated with normalised value. (Andreotti et al. 2018) 
ECG Frequency nLF Percentage of low and high frequency power in the low 
frequency range  
(Andreotti et al. 2018) 
ECG Frequency nHF  (Andreotti et al. 2018) 
ECG Frequency LFHF Ratio of low to high frequency power.  (Andreotti et al. 2018) 
ECG  PoincareSD1 Standard deviation in y=-x direction of Poincare plot. Also 
calculated with normalised value. 
(Andreotti et al. 2018) 
ECG  PoincareSD2 Standard deviation in y=x direction of Poincare plot. Also 
calculated with normalised value. 
(Andreotti et al. 2018) 
ECG Non-linear Sample 
Entropy 
Sample entropy. Also calculated with normalised value. (Andreotti et al. 2018) 
ECG Non-linear Approximate 
Entropy 
Approximate entropy. Also calculated with normalised value. (Andreotti et al. 2018) 
ECG Time RR Recurrence rate. (Andreotti et al. 2018) 
ECG  DET Determinism (Andreotti et al. 2018) 
ECG No-linear ENTR Shannon entropy.  (Andreotti et al. 2018) 
ECG  L Average diagonal line length.  (Andreotti et al. 2018) 
ECG Time TKEO Mean Teager-Kaiser energy operator. Also calculated with 
normalised value. 
(Andreotti et al. 2018) 
ECG  DAFa2 Detrended fluctuation analysis exponent.  (Andreotti et al. 2018) 
ECG  LZ Lempel Ziv complexity.  (Andreotti et al. 2018) 
ECG  BD Mutual information (Andreotti et al. 2018) 
ECG  PD Mutual information (Andreotti et al. 2018) 
ECG  BDa Auto-correlation (Andreotti et al. 2018) 
ECG  PDa Auto-correlation (Andreotti et al. 2018) 
ECG Time ZCI Zero crossing interval.  (Andreotti et al. 2018) 
ECG Time mZCI Mean zero crossing interval.  (Andreotti et al. 2018) 
ECG Time nsZCI Normalised zero crossing interval.  (Andreotti et al. 2018) 
ECG Time AmpVarsqi Variation of amplitude around QRS complex.  (Andreotti et al. 2018) 
ECG Time Ampstdsqi Standard deviation of amplitude around QRS complex. (Andreotti et al. 2018) 
ECG Time AmpMean Mean amplitude around QRS complex.  (Andreotti et al. 2018) 
ECG Time Tachy Tachycardia ( > 100 beats per minute (bpm) in adults) (Andreotti et al. 2018) 
ECG Time Brady Bradycardia ( < 60 bpm in adults) (Andreotti et al. 2018) 
EOG Time Percent 
Differential 
This feature is calculated by taking the difference between the 
75th and the 25th percentile. The 75th and 25th percentile is 
defined by the amplitude, below which represents 75% and 
25% of the random value, respectively.   
(Lajnef et al. 2015) 
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Channel Category Name Description Reference 
EOG Time Mean, 
Minimum, & 
Maximum 
Coastline 
Calculated by summating the absolute derivatives of the signal. 
The coastline is determined for each mini-epoch, where the 
mean, minimum and maximum can be calculated for a given 
30s epoch. 
(Yetton et al. 2016) 
EOG Time Autocorrelati
on 
The peak of the autocorrelation sequence of every mini-epoch 
was calculated. The autocorrelation gives an indication of a 
pattern within a given mini-epoch, enhancing REM spikes 
within the EOG signal. 
(Yetton et al. 2016) 
EMG/EOG Time Variance The variance of each mini-epoch.  
EOG Time Kurtosis The measure of kurtosis for each epoch.  
EOG Time Skewness Measure of skewness for each epoch.   
EOG Non-linear Teager-
Kaiser 
Energy 
Operator 
The mean of the Teager-Kaiser Energy Operator (TKEO) was 
calculated. 
(Lajnef et al. 2015) 
EOG Time Max Peak The maximum absolute peak of each mini-epoch was detected 
as a feature (positive or negative). 
(Yetton et al. 2016) 
EOG Time Second Max 
Peak 
The second largest maximum absolute peak of each mini-epoch 
was detected as a feature (positive or negative). 
(Yetton et al. 2016) 
EOG Time Peak 
Prominence  
This is a measure of how much peaks stand out compared to 
other surrounding peaks.  
(Yetton et al. 2016) 
EOG Time Peak Width The width of a peak is the distance between two points, left 
and right of the peak, which intercept a vertical distance from 
the peak of half the peak prominence.  
(Yetton et al. 2016) 
EOG Time Rise  The slope on the rise to the peak. (Yetton et al. 2016) 
EOG Time Fall The slope on the fall from the peak.  (Yetton et al. 2016) 
EOG Time Mean, 
maximum, 
and variance 
of 
Differential 
The average differential value is calculated for every mini-
epoch, where the average and the maximum value across the 
30s epoch is determined. 
(this work) 
EOG Frequency Power Ratio 
(0.5Hz/4Hz) 
The power ratio between the 0-4Hz band and the entire 
spectrum was calculated. 
(Susmáková and 
Krakovská 2008) 
EOG Wavelet Discrete 
Wavelet 
Transform 
(DWT) - 
Haar/DB2 
The DWT was applied using 4 levels of decomposition and 
used the maximum amplitude of the -4 level inverse DWT as 
the feature. The larger the amplitude of the inverse DWT signal 
the more the signal can be composed of wavelets and also 
more likely that the window contains REM 
(Yetton et al. 2016) 
EOG Non-linear Permutation 
Entropy 
Permutation entropy is a nonlinear measure that characterises 
the complexity of a time series. For every mini-epoch the 
permutation entropy was calculated to the 10th order.  
(Lajnef et al. 2015) 
EMG Time Atonia Index The distribution of amplitude values (averaged and corrected) 
for a given 30s epoch are used to determine the percentage of 
values ≤ 1μV (excluding values > 1µV and < 2µV).  
(Ferri et al. 2010) 
EMG Time Energy For every epoch the mean rectified amplitude is calculated.  (Hsu et al. 2013) 
EMG Time 75th 
Percentile 
The 75th percentile, detailing the value which 75% of the 
variable is below.  
(Charbonnier et al. 
2011) 
EMG Time Entropy The variability of the signal is calculated as follows, where 𝑃𝑖 is 
the histogram count of values using 256 bins: 
(Charbonnier et al. 
2011) 
EMG Time Motor 
Activity 
An algorithm that derives a signal to measure motor activity 
and a threshold (baseline) to determine when there is 
movement. The threshold is then used to determine the 
duration of motor activity within each epoch.   
(Frandsen et al. 2015) 
EMG Frequency Fractal 
Exponent 
The negative slope of the spectral density using a logarithmic 
on both the frequency and power. 𝑃(𝑓)~𝑓−𝛼 
(Susmáková and 
Krakovská 2008) 
EMG Frequency Absolute 
Gamma 
Power 
The average power in the gamma frequency range (30-100Hz). (Susmáková and 
Krakovská 2008) 
EMG Frequency Relative 
Power 
The ratio of the average frequency power between the high 
frequency range (12.5-21Hz) and the total frequency band (8-
32Hz). 
(Charbonnier et al. 
2011) 
EMG Frequency Spectral 
Edge 
Frequency 
The highest frequency at which 95% of the total signal power 
is located. 
(Charbonnier et al. 
2011) 
EMG Time Standard 
Deviation 
The standard deviation of the amplitude for each epoch.   
NA Time Hours 
Recorded 
The nature of sleep architecture means the progress of time 
provides details on the likelihood of having REM, therefore the 
number of hours into PSG recordings is also used as a feature. 
(this work) 
NA Time Hours From 
End 
Time in hours from the end of the recording. This features 
provides information on likelihood of wake and REM.  
(this work) 
Table 2: Features extracted from ECG, EOG, and EMG signals. 
19 
 
Channel Category Name Description Reference 
ECG Time RR_REM_Std The mean RR interval standard deviation during all 
REM epochs. 
(Andreotti et al. 2018) 
ECG Frequency LFpeak_NREM The mean RR interval low frequency peak during 
NREM epochs.  
(Andreotti et al. 2018) 
ECG Frequency LFpeak_REM The mean RR interval low frequency peak during 
REM epochs.  
(Andreotti et al. 2018) 
ECG Frequency HFpeak_NREM The mean RR interval high frequency peak during 
NREM epochs.  
(Andreotti et al. 2018) 
ECG Frequency HFpeak_REM The RR interval high frequency peak during REM 
epochs.  
(Andreotti et al. 2018) 
ECG Time RR_Index_REMNREM The mean RR interval ratio between REM and 
NREM epochs.  
This work. 
NA Time Ratio_NREM Ratio of NREM sleep compared to all other stages.  This work 
ECG  Frequency LFHF_Index_REMNREM The mean RR interval low frequency to high 
frequency ratio between NREM and REM epochs.  
This work 
ECG Non-linear IrrIndex_NREM The mean irregular index. Originally termed atrial 
fibrillation evidence.  
(Sarkar et al. 2008) 
ECG Non-linear IrrIndex_REM The mean irregular index calculated for each REM 
epoch. Originally termed atrial fibrillation evidence. 
(Sarkar et al. 2008) 
ECG Non-linear OriginCount_NREM A parameter calculated for the irregular index that 
measured the number of regular heart beat 
intervals for each 30s epoch and then averaged 
using a sliding 150s window. This metric calculates 
the mean origin count for all NREM epochs.  
(Sarkar et al. 2008) 
ECG Non-linear OriginCount_REM Similar to Origin_Count_NREM, where this metric 
calculates the mean origin count for all REM epochs. 
(Sarkar et al. 2008) 
ECG Non-linear SampEn_REM The mean sample entropy during REM.  (Andreotti et al. 2018) 
Table 3: ECG metrics for RBD detection, which aim to capture changes in HRV during sleep. 
Sleep Staging Signals #Features  #Sensors ID 
ECG  75 1 A1 
EOG 25 1 B1 
EMG  17 1 C1 
ECG+EOG 98 2 A2 
ECG+EMG 90 2 B2 
EOG+EMG 40 2 C2 
ECG+EOG+EMG 113 3 A3 
EEG+EOG+EMG 128 3 Z3 
Table 4: Combination of austere PSG sensors to be used and analysed for automated sleep staging (three state). The Z3 
combination is based on our previous study and used as a comparison (Cooray et al. 2019). 
RBD Detection Signals #Features Total Sensors ID 
ECG  11 1 D1 
EMG  7 1 E1 
ECG+EMG 18 2 D2 
Table 5: These are the austere PSG sensors to be analysed for RBD detection in coordination with automated sleep staging.  
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Figure 1: The depiction of REM detection performance for various PSG signal combinations. For a single sensor (A1, B1, and 
C1) the best sensitivity and F1 score is given by the EOG signal (B1). For two sensors, (A2, B2, C2), the best performance is 
given by EOG and EMG (C2). This exceeds the performance of a single EOG sensor (B1), which is illustrated by the increase in 
sensitivity, while maintaining an equal specificity.  
 W NREM REM 
Accuracy 0.79±0.09 0.72±0.08 0.87±0.06 
Sensitivity 0.42±0.17 0.90±0.09 0.13±0.19 
Specificity 0.91±0.08 0.37±0.16 0.98±0.06 
Precision 0.59±0.19 0.72±0.10 0.38±0.35 
F1 0.45±0.12 0.80±0.08 0.16±0.19 
Kappa 0.34±0.13 0.30±0.13 0.13±0.18 
 
 W NREM REM 
Accuracy 0.85±0.10 0.81±0.098 0.93±0.047 
Sensitivity 0.64±0.21 0.90±0.12 0.60±0.31 
Specificity 0.92±0.11 0.66±0.18 0.98±0.022 
Precision 0.73±0.20 0.83±0.096 0.76±0.22 
F1 0.64±0.17 0.85±0.097 0.62±0.27 
Kappa 0.56±0.19 0.57±0.18 0.59±0.27 
 
(a) (b) 
Table 6: Performance of automatic sleep stage classification using (a) ECG features and (b) combined EOG and EMG features. 
For (a) performance is relatively low compared to literature on ECG sleep staging, but interestingly this is overwhelmingly due 
to performance on RBD participants, where sensitivity is many times smaller than HCs. The performance of (b) is substantially 
better than using an ECG feature and a single EOG feature.  
  
(a) (b) 
Figure 2: The order of feature importance for automated sleep staging (REM detection) using (a) ECG features compared with 
(b) ECG, EOG, and EMG features. The elapsed recording time represents the top two features for (a) followed by ZCI and RR 
interval based features. Also highly represented are the ECG amplitude based features such as amplitude mean and, variance 
and stdsqi. For (b) the EOG features prove most important for REM detection, specifically permutation entropy, max peak 
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and coastline features. Followed by elapsed recording time and EMG features, such as the 75th percentile, entropy, relative 
power and motor activity. These additional features from another signal provide the boost in REM detection performance 
shown in Figure 1.   
 
Figure 3: Performance of RBD detection using ECG (D1), EMG (E1), and both ECG and EMG signals (D2) with manually 
annotated sleep stages. With annotations ECG features (D1) prove effective at RBD identification, but are clearly 
outperformed by an EMG sensors (E1). Combining these sensors (D2) only improves performance marginally with respect to 
the F1 score.   
   
(a) (b) (c) 
Figure 4: Features importance for RBD detection using (a) ECG, (b) EMG and (c) both EMG and ECG metrics. From the ECG 
features (a), irregular evidence during NREM proves the most effective for RBD detection, followed by the LFHF index ratio 
between REM and NREM. 
 
Figure 5: RBD Detection performance when using automated sleep staging. For this figure B1, C2 and A3 represent automated 
sleep staging using only EOG, both EOG and EMG, or ECG, EOG and EMG features, respectively. D1, E1 and D2 represent 
metrics derived from EMG, ECG, and both EMG and ECG sensors for RBD detection, used in combination with automated 
sleep staging. 
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RBD Detection 
RBD Detection using Automatic Sleep Staging 
Accuracy Sensitivity Specificity F1 
Atonia Index 0.83±0.12 0.68±0.22 0.98±0.06 0.78±0.18 
RF (EMG Features) 0.90±0.11 0.88±0.13 0.92±0.098 0.90±0.12 
RF (ECG Features) 0.65±0.22 0.70±0.24 0.60±0.24 0.66±0.21 
RF (EMG+ECG Features) 0.92±0.098 0.88±0.13 0.96±0.08 0.91±0.11 
Table 7: RBD Detection results using automatically annotated sleep stages. Automated sleep stages achieved using EOG and 
EMG features.  
 
   
 (a)  (b)   (c) 
   
(d) (e) (f) 
Figure 6: Bland and Altman plots of important RBD metrics comparing scores derived from manually and automatically 
annotated sleep stages. These include the (a) atonia index during REM, (b) atonia index ratio between REM and NREM, (c) 
fractal exponent ratio between REM and NREM, (d) irregular index during NREM, (e) RR interval index between REM and 
NREM, and (f) origin count during NREM. In all cases we can observe that metrics are within the limits of agreement. The P-
value details the Kolmogorov-Smirnov test to determine if the difference between metrics calculated from manual and 
automatic sleep staging is from a normal distribution (rejected when < 0.05). For metrics shown above, the line of equality 
(the zero dotted line) doesn’t fall within the limits of confidence around the mean difference. Therefore when using automated 
sleep staging the calculated metrics for RBD detection slightly shifts towards values associated with RBD or HC participants. 
This is unsurprising given misclassification from automated sleep staging will have an impact on the calculation of these 
metrics. 
 
 
